Ilumya® (tildrakizumab-asmn) approved in the U.S. for the Treatment of Adults with Active Psoriatic Arthritis PR Newswire (Press Release) 13h
Sun Pharma shares rise 2%; gets US FDA approval for Ilumya to treat psoriatic arthritis The Financial Express 17h
Butter recalled over yeast, mold and E.coli concerns gets FDA risk classification ABC News 2d All sources
FDA issues alert about beds sold by Medline after deaths, injuries Daily Breeze 1h Medline All sources
Sun Pharma shares rise 2%; gets US FDA approval for ILUMYA to treat psoriatic arthritis The Financial Express 17h ILUMYA Psoriatic arthritis Sun Pharma
